Condition: Colorectal Cancer · Breast Cancer · Sponsor: Ain Shams University
The goal of this observational study is to study the effect of a single nucleotide polymorphism in the CES1 gene (rs2244613) on capecitabine-induced toxicity in Egyptian cancer patients. This study will help in understanding the interindividual variability in the CES1 gene and the effect of a single nucleotide polymorphism in this gene (rs2244613) on capecitabine-induced toxicity in participants already taking capecitabine-based chemotherapy as part of their regular medical care.
This description comes directly from the study's public registry record.
Raghad Nassar, Teaching Assistant · 01004446077 · raghad.essam22@pharma.asu.edu.eg
Always discuss trial participation with your own doctor first.
| Department of Clinical Oncology, Faculty of Medicine, Menoufia University | Shibīn al Kawm, Menoufia, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06765252